GENERAL SESSIONS │ 8:00 am – 11:45 am


8:00 am – 8:10 am
Announcements and Pretest
Rishi P. Singh, MD

Surgical Technology

Session Chairs: David R. Chow, MD, FRCSC; Rishi P. Singh, MD
8:10 am – 8:17 am
Hybrid Wide-angle Viewing and Endoscopic Vitrectomy Using a 3D Visualization System
Mihori Kita, MD, PhD
8:17 am – 8:24 am
Science of 3D Visualization Systems
David R. Chow, MD, FRCSC
8:24 am – 8:31 am
Advancements in Visualization in VR Surgery
Khalid Sabti, MD, FRCSC

Abstract Winner

8:31 am – 8:34 am
Innovative Solutions for HD/4k Surgical Video Recording Using Commercial Mirror-less Cameras
Raju Sampangi, MD

Panel Discussion

8:35 am – 8:55 am
Instrumentation in the OR
Moderator: David R. Chow, MD, FRCSC
Panelists: Carl C. Awh, MD; Faisal Fayyad, MD; Stratos Gotzaridis, MD; John W. Kitchens, MD

Retinal Detachment Surgery

Session Chairs: Ehab N. El Rayes, MD, PhD; Kourous A. Rezaei, MD; Stanislao Rizzo, MD
9:00 am – 9:07 am
Temporal Keratoprothesis and Vitrectomy
Andres Bastien, MD
9:07 am – 9:14 am
Chandelier Illumination for Scleral Buckling
Nur Acar Gocgil, MD, Prof, FEBO
9:14 am – 9:21 am
Managing Macular Folds in Infants
Ehab N. El Rayes, MD, PhD
9:21 am – 9:28 am
Repairing Retinal Detachments: Do We Really Need Gas?
Ernesto Bali, MD
9:28 am – 9:35 am
Retinal Detachment from Macular Hole
Marcio B. Nehemy, MD, PhD
9:35 am – 9:42 am
ILM Peeling During Retinal Detachment Surgery: Is It Necessary?
Ezequiel Rosendi, MD

Abstract Winners

9:42 am – 9:45 am
Seasonal Variation in the Occurrence of Rhegmatogenous Retinal Detachment in Korea: A Three-year Nationwide Study of the Korean Population
Sung Soo Kim, MD
9:45 am – 9:48 am
Reabsorption of Acquired Vitelliform Lesions Due to Vitreomacular Traction Syndrome
Gürsel Yilmaz, MD, FACS, FEBO
9:48 am – 9:51 am
"Cell Therapy" Clinics for Retinal Conditions in the USA: Assessing Direct-to-Consumer Marketing
Rajinder Nirwan, MD

Refreshment Break

9:51 am – 10:25 am
Refreshments in the Exhibit Hall


Session Chairs: Peter K. Kaiser, MD; Taiji Sakamoto, MD, PhD; Lihteh Wu, MD
10:25 am – 10:30 am
Peter K. Kaiser, MD
10:30 am – 10:37 am
Optical Coherence Tomography Angiography in Pediatric Patients
Lejla Vajzovic, MD
10:37 am – 10:44 am
Angiogenic Biomarkers in Neovascular AMD
Luiz H. Lima, MD
10:44 am – 10:51 am
Quantitative Comparison of UWF Imaging Devices
Ajay E. Kuriyan, MD, MS
10:51 am – 10:58 am
How Optical Coherence Tomography Angiography Changes My Practice
Miho Nozaki, MD, PhD
10:58 am – 11:05 am
Agreement Between OCT Angiography and FA/ICG in Neovascular AMD
Nadia K. Waheed, MD, MPH
11:05 am – 11:12 am
OCT Angiography in CNV: Are There Parameters That Predict Anti-VEGF Treatment Frequency?
Amani A. Fawzi, MD
11:12 am – 11:19 am
Multimodal Imaging in Polypoidal Choriodovasculopathy
Seung-Young Yu, MD, PhD
11:19 am – 11:26 am
Comparison of Ultra-widefield Imaging Devices
Claudia P. Acosta, MD

Panel Discussion

11:30 am – 11:50 am
Moderator: Jay S. Duker, MD
Panelists: Claudia P. Acosta, MD; Gemmy Cheung, MD; Andre Romano, MD; Richard B. Rosen, MD, ScD (Hon), FACS, FASRS, CRA; Nadia K. Waheed, MD, MPH

INDUSTRY EXPERT THEATER LUNCH** │ 12:00 pm – 1:00 pm

12:00 pm – 1:00 pm
Diabetic Retinopathy Management – A Multidisciplinary Discussion
Sponsored by Genentech **This portion of the meeting is not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina World Congress 2019 or its accredited provider.

GENERAL SESSIONS │ 1:15 pm – 6:30 pm

Imaging (Continued)

Session Chairs: Peter K. Kaiser, MD; Taiji Sakamoto, MD, PhD; Lihteh Wu, MD
1:15 pm – 1:18 pm
Peter K. Kaiser, MD
1:18 pm – 1:25 pm
Adaptive Optics Imaging in a Retina Practice
Mina M. Chung, MD
1:25 pm – 1:32 pm
Ultra-widefield Imaging and Diabetic Retinopathy
Justis P. Ehlers, MD
1:32 pm – 1:39 pm
Ultra-widefield OCTA and Retinal Vein Occlusion
Kasra A. Rezaei, MD
1:39 pm – 1:46 pm
Classification and Guidelines for Wide Field Imaging: Recommendations from the International Wide Field Imaging Study Group
Netan Choudhry, MD, FRCSC, DABO
1:46 pm – 1:53 pm
Multimodal Retinal Imaging for Alzheimer's Disease
Sharon Fekrat, MD, FACS
1:53 pm – 2:00 pm
Mac Tel 2: A Multimodal Imaging Journey
Lihteh Wu, MD
2:00 pm – 2:07 pm
Artificial Intelligence and Choroidal Imaging
Taiji Sakamoto, MD, PhD

Abstract Winners

2:07 pm – 2:10 pm
Higher Order OCT Analysis for Features Associated with Functional Outcomes in the VISTA-DME Study
Atsuro Uchida, MD
2:10 pm – 2:13 pm
Optical Coherence Tomography Angiography Findings in Chronic Central Serous Chorioretinopathy after Photodynamic Therapy
Ruwan Amila Silva, MD
2:13 pm – 2:15 pm
Peter K. Kaiser, MD

Age-related Macular Degeneration

Session Chairs: André V. Gomes, MD, PhD; Rishi P. Singh, MD
2:20 pm – 2:23 pm
Rishi P. Singh, MD
2:23 pm – 2:30 pm
AMD, Genetic Testing and AREDS Supplements
Carl C. Awh, MD
2:30 pm – 2:37 pm
Prevention of Exudative AMD in High Risk Eyes
Sumit P. Shah, MD, FACS
2:37 pm – 2:44 pm
Geographic Atrophy Associated with AMD, Incidence and Factors Influencing Growth Rate
Nancy M. Holekamp, MD
2:44 pm – 2:51 pm
C3 Complement Inhibition for the Reduction of Growth in Geographic Atrophy
Nathan C. Steinle, MD
2:51 pm – 2:58 pm
Brimonidine for Geographic Atrophy Secondary to Age-related Macular Degeneration
Raj K. Maturi, MD
2:58 pm – 3:05 pm
Gene Therapy for Dry AMD
Elias Reichel, MD
3:05 pm – 3:12 pm
Emerging Therapies on Dry AMD
Paolo Lanzetta, MD
3:12 pm – 3:19 pm
Evaluating the Social Costs of Blindness from AMD
Andrew A. Moshfeghi, MD, MBA
3:19 pm – 3:26 pm
Real-world Anti-VEGF Treatment for AMD
Patricio G. Schlottmann, MD
3:26 pm – 3:30 pm
Rishi P. Singh, MD<

Refreshment Break

3:30 pm – 3:50 pm
Refreshments in the Exhibit Hall

Age-related Macular Degeneration (Continued)

Session Chairs: André V. Gomes, MD, PhD; Rishi P. Singh, MD
3:50 pm – 3:52 pm
Rishi P. Singh, MD
3:52 pm – 3:59 pm
Angiopoietin Pathway in Neovascular Diseases
Peter K. Kaiser, MD
3:59 pm – 4:06 pm
Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Exudative AMD
Carl D. Regillo, MD, FACS
4:06 pm – 4:13 pm
Treat and Extend Regimens for Exudative AMD
Alexandre A. Ventura, MD, PhD
4:13 pm – 4:20 pm
A Comparison of Brolucizumab and Aflibercept in Neovascular Age-related Macular Degeneration: Important Subanalyses
Pravin U. Dugel, MD
4:20 pm – 4:27 pm
Association Between Early Vision-related Quality of Life Outcomes and Anatomic Dryness Response in Neovascular Age-related Macular Degeneration (nAMD)
David A. Eichenbaum, MD
4:27 pm – 4:34 pm
Emerging Therapies for Exudative AMD
David S. Boyer, MD

Abstract Winners

4:38 pm – 4:41 pm
Brolucizumab for Neovascular AMD: The 2-year HAWK and HARRIER Results
Peter K. Kaiser, MD
4:41 pm – 4:44 pm
Evaluating Efficacy of Autologous Bone Marrow Derived Stem Cells in the Treatment of Dry Age-related Macular Degeneration
Harpreet Narde, MD
4:44 pm – 4:47 pm
Macular Atrophy in Anti-VEGF Treated Neo-vascular AMD: Incidence and Risk Factors
João Pedro Marques, MD, Msc
4:47 pm – 4:50 pm
PDT Associated with Anti-VEGF in Refractory Cases of Subretinal Membranes Only Treated with Anti-VEGF
Jorge Mitre, MD
4:50 pm – 4:53 pm
Efficacy and Safety of Brimonidine DDS for Geographic Atrophy Secondary to Age-related Macular Degeneration: BEACON Phase 2b Clinical Results
Sunir J. Garg, MD, FACS

Panel Discussion

4:55 pm – 5:15 pm
Age-related Macular Degeneration
Moderator: Sunir J. Garg, MD, FACS
Panelists: Panelists: Remzi Avci, MD Paolo Lanzetta, MD; Luiz H. Lima, MD; Carl D. Regillo, MD, FACS; Elias Reichel, MD; Richard B. Rosen, MD, ScD (Hon), FACS, FASRS, CRA

Diabetic Vitrectomy

Session Chairs: Sundaram Natarajan, MD; Kourous A. Rezaei, MD
5:19 pm – 5:22 pm
Kourous A. Rezaei, MD
5:22 pm – 5:29 pm
Intravitreal Anti-VEGF as an Adjunct to Vitrectomy Surgery for Diabetic Tractional Retinal Detachment
J. Fernando Arevalo, MD, FACS
5:29 pm – 5:36 pm
Role of Patient Compliance in the Development of Sight Threatening Diabetic Retinopathy
Shwu-Jiuan Sheu, MD
5:36 pm – 5:43 pm
All-probe Vitrectomy Dissection Techniques for Diabetic Tractional Retinal Detachments: Lift and Shave
Maria H. Berrocal, MD
5:43 pm – 5:50 pm
3D Surgery for Diabetic Surgery
Marco Mura, MD
5:50 pm – 5:57 pm
Combined Maneuvers in Proliferative Diabetic Surgery
André V. Gomes, MD, PhD
5:57 pm – 6:04 pm
Steroid Drops after Vitreoretinal Surgery: Is It Time to go Drop-less?
John S. Pollack, MD

Abstract Winners

6:04 pm – 6:07 pm
Early Vitrectomy in Proliferative Diabetic Retinopathy without High Risk
Eva Dewi, MD
6:07 pm – 6:10 pm
The Role of SD-OCT Defining the Posterior Vitreous Status: A Comparison with Ocular Ultrasonography
Bernardete Pessoa, MD
6:10 pm – 6:12 pm
Kourous A. Rezaei, MD

Panel Discussion

6:15 pm – 6:35 pm
Diabetic Vitrectomy
Moderator: J. Fernando Arevalo, MD, FACS
Panelists: Remzi Avci, MD; Niels Crama, MD, FEBO; Ehab N. El Rayes, MD, PhD; Francesco Faraldi, MD; John S. Pollack, MD; Stratos Gotzaridis, MD; Marcelo Zas, MD, PhD